Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Sana Biotechnology Inc.

    NASDAQ: SANA · Real-Time Price · USD
    2.61
    -0.15 (-5.43%)
    At close: Jun 20, 2025, 3:59 PM
    2.70
    3.45%
    After-hours: Jun 20, 2025, 04:43 PM EDT

    Sana Biotechnology Statistics

    Share Statistics

    Sana Biotechnology has 225.56M shares outstanding. The number of shares has increased by 1.59% in one year.

    Shares Outstanding

    n/a
    		 225.56M

    Shares Change (YoY)

    n/a
    		 1.59%

    Shares Change (QoQ)

    n/a
    		 0.79%

    Owned by Institutions (%)

    n/a
    		 67.13%

    Shares Floating

    n/a
    		 125.44M

    Failed to Deliver (FTD) Shares

    n/a
    		 3,145

    FTD / Avg. Volume

    n/a
    		 0.08%

    Short Selling Information

    The latest short interest is 44.26M, so 19.62% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 44.26M

    Short % of Shares Out

    n/a
    		 19.62%

    Short % of Float

    n/a
    		 77.8%

    Short Ratio (days to cover)

    n/a
    		 10.07

    Valuation Ratios

    The PE ratio is -1.41 and the forward PE ratio is -3.89. Sana Biotechnology's PEG ratio is 0.07.

    PE Ratio

    n/a
    		 -1.41

    Forward PE

    n/a
    		 -3.89

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 6.7

    PB Ratio

    n/a
    		 1.5

    P/FCF Ratio

    n/a
    		 -1.47

    PEG Ratio

    n/a
    		 0.07
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Sana Biotechnology.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.54, with a Debt / Equity ratio of 0.38.

    Current Ratio

    n/a
    		 3.54

    Quick Ratio

    n/a
    		 3.54

    Debt / Equity

    n/a
    		 0.38

    Debt / EBITDA

    n/a
    		 -0.37

    Debt / FCF

    n/a
    		 -0.37

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,375,046.39

    Employee Count

    n/a
    		 194

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -47.23% in the last 52 weeks. The beta is 1.79, so Sana Biotechnology's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.79

    52-Week Price Change

    n/a
    		 -47.23%

    50-Day Moving Average

    n/a
    		 2.02

    200-Day Moving Average

    n/a
    		 2.83

    Relative Strength Index (RSI)

    n/a
    		 62.89

    Average Volume (20 Days)

    n/a
    		 3,712,522

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -272.72M

    Net Income

    n/a
    		 -266.76M

    EBITDA

    n/a
    		 -251.27M

    EBIT

    n/a
    		 -266.76M

    Earnings Per Share (EPS)

    n/a
    		 -1.16
    Full Income Statement

    Balance Sheet

    The company has 127.57M in cash and 94.2M in debt, giving a net cash position of 33.37M.

    Cash & Cash Equivalents

    n/a
    		 127.57M

    Total Debt

    n/a
    		 94.2M

    Net Cash

    n/a
    		 33.37M

    Retained Earnings

    n/a
    		 -1.6B

    Total Assets

    n/a
    		 445.47M

    Working Capital

    n/a
    		 79.58M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -223.15M and capital expenditures -33.43M, giving a free cash flow of -256.58M.

    Operating Cash Flow

    n/a
    		 -223.15M

    Capital Expenditures

    n/a
    		 -33.43M

    Free Cash Flow

    n/a
    		 -256.58M

    FCF Per Share

    n/a
    		 -1.11
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    SANA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for SANA is $9, which is 226.1% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $9

    Price Target Difference

    n/a
    		 226.1%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 6
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -5.25

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist